Regeneron Sets Foot in Hyderabad: A New Era for Global Life Sciences
Regeneron Pharmaceuticals has announced plans to establish its Global Capability Centre (GCC) in Hyderabad, India, set to be operational by the latter half of 2026. The new GCC will heavily bolster Regeneron's operations through advancements in areas like data management, artificial intelligence, and clinical trials, generating hundreds of new roles.
US-based Regeneron Pharmaceuticals revealed its plan to inaugurate a Global Capability Centre (GCC) in Hyderabad by mid-2026. This strategic expansion aims to augment its reach in India's burgeoning life sciences sector.
The upcoming GCC is poised to create numerous jobs and support various facets of Regeneron's global operations, including data management, AI, and clinical trials. This move further entrenches Hyderabad as a pivotal life sciences hub.
Telangana's IT and Industries Minister, Sridhar Babu, lauds the investment as a boon for the state's life sciences ecosystem, aligning with Hyderabad's growing prominence in pharmaceuticals and biotechnology.
(With inputs from agencies.)
Advertisement
ALSO READ
Venture investments halve in Apr to USD 2.7 bn as rupee depreciation weighs on sentiment
Venture investments halve in Apr to USD 2.7 bn as rupee depreciation weighs on sentiment
Centre, Raj govt woo investments in electronics and semiconductor manufacturing
Goyal to visit Canada next week to boost FTA talks, investments
Working on several sectoral proposals to promote investments: Goyal
Google News